| Literature DB >> 34763384 |
Hirokazu Saito1, Yoshihiro Kadono2, Takashi Shono3, Kentaro Kamikawa4, Atsushi Urata4, Jiro Nasu5, Haruo Imamura4, Ikuo Matsushita3, Tatsuyuki Kakuma6, Shuji Tada1.
Abstract
BACKGROUND/AIMS: Difficult biliary cannulation is an important risk factor for post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). Therefore, this study aimed to identify the factors that predict difficult cannulation for common bile duct stones (CBDS) to reduce the risk for PEP.Entities:
Keywords: Cannulation; Common bile duct stone; Endoscopic retrograde cholangiopancreatography; Factor
Year: 2021 PMID: 34763384 PMCID: PMC8995991 DOI: 10.5946/ce.2021.153
Source DB: PubMed Journal: Clin Endosc ISSN: 2234-2400
Baseline Characteristics
| All patients | Propensity score-matched patients | |||||
|---|---|---|---|---|---|---|
| With difficult cannulation ( | Without difficult cannulation ( | With difficult cannulation ( | Without difficult cannulation ( | |||
| Age (mean, [SD]) (years) | 75.2 (13.8) | 74.6 (14.0) | 0.39 | 74.1 (14.3) | 74.5 (14.8) | 0.82 |
| Age less than 60 years (5%) | 89 (14.8) | 124 (15.4) | 0.82 | 40 (18.1) | 40 (18.1) | 1.0 |
| Female gender (%) | 297 (49.5) | 371 (46.0) | 0.21 | 113 (51.1) | 103 (46.6) | 0.39 |
| Billroth-I reconstruction (%) | 21 (3.5) | 19 (2.4) | 0.26 | 9 (4.1) | 8 (3.6) | 1.0 |
| Performance status 3 or 4 (%) | 105 (17.5) | 152 (18.9) | 0.53 | 39 (17.6) | 37 (16.7) | 0.90 |
| End-stage renal failure requiring dialysis (%) | 20 (3.3) | 22 (2.7) | 0.53 | 10 (4.5) | 5 (2.3) | 0.29 |
| Normal serum bilirubin (%) | 299 (49.8) | 331 (41.1) | 0.001 | 104 (47.1) | 97 (43.9) | 0.57 |
| Nondilated CBD (<10 mm) (%) | 243 (40.5) | 331 (41.1) | 0.87 | 85 (38.5) | 88 (39.8) | 0.85 |
| Large CBD stones (>10 mm) (%) | 106 (17.7) | 148 (18.4) | 0.78 | 40 (18.1) | 42 (19.0) | 0.90 |
| Multiple CBD stones (≥2 stones) (%) | 232 (38.7) | 345 (42.8) | 0.13 | 91 (41.2) | 84 (38.0) | 0.56 |
| Intradiverticular papilla (%) | 35 (5.8) | 25 (3.1) | 0.016 | 12 (5.4) | 14 (6.3) | 0.84 |
| ERCP performed by non-expert endoscopists | 141 (23.5) | 79 (9.8) | <0.001 | 44 (19.9) | 51 (23.1) | 0.49 |
| Contrast-assisted cannulation (%) | 274 (45.7) | 731 (90.7) | <0.001 | 176 (79.6) | 176 (79.6) | 1.0 |
| PGW-assisted cannulation (%) | 182 (30.3) | 4 (0.5) | <0.001 | 9 (4.1) | 4 (1.8) | 0.26 |
| Wire-guided cannulation (%) | 69 (11.5) | 71 (8.8) | 0.11 | 31 (14.0) | 41 (18.6) | 0.25 |
| Pancreatic injection (%) | 428 (71.3) | 199 (24.7) | <0.001 | 107 (48.4) | 110 (49.8) | 0.85 |
| EST (%) | 512 (85.3) | 714 (88.6) | 0.076 | 194 (87.8) | 191 (86.4) | 0.78 |
| EPBD (%) | 74 (12.3) | 89 (11.0) | 0.50 | 25 (11.3) | 29 (13.1) | 0.66 |
| EPLBD (%) | 79 (13.2) | 134 (16.6) | 0.084 | 38 (17.2) | 37 (16.7) | 1.0 |
| Precut sphincterotomy (%) | 75 (12.5) | 0 (0.0) | <0.001 | 5 (2.3) | 0 (0.0) | 0.061 |
| Attempted stone removal (%) | 560 (93.3) | 785 (97.4) | <0.001 | 211 (95.5) | 209 (94.6) | 0.83 |
| Balloon (%) | 474 (79.0) | 650 (80.6) | 0.46 | 179 (81.0) | 182 (82.4) | 0.81 |
| Basket (%) | 255 (42.5) | 384 (47.6) | 0.058 | 98 (44.3) | 99 (44.8) | 1.0 |
| Mechanical lithotripsy (%) | 110 (18.3) | 112 (13.9) | 0.027 | 42 (19.0) | 44 (19.9) | 0.90 |
| Biliary stent placement (%) | 513 (85.5) | 686 (85.1) | 0.88 | 194 (87.8) | 188 (85.1) | 0.49 |
| Prophylactic pancreatic stent placement (%) | 153 (25.5) | 38 (4.7) | <0.001 | 24 (10.9) | 23 (10.4) | 1.0 |
| Complete stone removal (%) | 555 (92.5) | 783 (97.1) | <0.001 | 210 (95.0) | 208 (94.1) | 0.83 |
| Rectal NSAIDs (%) | 57 (9.5) | 71 (8.8) | 0.71 | 23 (10.4) | 26 (11.8) | 0.76 |
| Protease inhibitor (%) | 247 (41.2) | 235 (29.2) | <0.001 | 104 (47.1) | 87 (39.4) | 0.12 |
| Prolonged procedure time (>30min) (%) | 321 (53.5) | 76 (9.4) | <0.001 | 63 (28.5) | 61 (27.6) | 0.92 |
| Procedure time (mean, [SD]) (min) | 36.6 (16.5) | 19.5 (9.4) | <0.001 | 27.6 (9.4) | 27.0 (12.4) | 0.63 |
CBD, common bile duct; EPBD, endoscopic papillary balloon dilation; EPLBD, endoscopic papillary large balloon dilation; ERCP, endoscopic retrograde cholangiopancreatography; EST, endoscopic sphincterotomy; NSAIDs, nonsteroidal anti-inflammatory drugs; PEP, post-endoscopic retrograde cholangiopancreatography pancreatitis; PGW, pancreatic guidewire; SD, standard deviation.
Rate of post-ERCP Pancreatitis
| All patients | Propensity score-matched patients | |||||
|---|---|---|---|---|---|---|
| With difficult cannulation ( | Without difficult cannulation ( | With difficult cannulation ( | Without difficult cannulation ( | |||
| PEP (%) | 50 (8.3%) | 13 (1.6%) | <0.001 | 12 (5.4%) | 3 (1.4%) | 0.032 |
ERCP, endoscopic retrograde cholangiopancreatography; PEP, post-endoscopic retrograde cholangiopancreatography pancreatitis.
Univariate Analysis for Factors Predicting Difficult Biliary Cannulation
| With difficult cannulation ( | Without difficult cannulation ( | ||
|---|---|---|---|
| Age (mean, [SD]) (years) | 75.2 (13.8) | 74.6 (14.0) | 0.39 |
| Female gender (%) | 297 (49.5) | 371 (46.0) | 0.21 |
| Absence of acute cholangitis (%) | 238 (39.7) | 243 (30.1) | <0.001 |
| Normal serum bilirubin (%) | 299 (49.8) | 331 (41.1) | 0.001 |
| Nondilated CBD (<10 mm) (%) | 243 (40.5) | 331 (41.1) | 0.87 |
| Performance status 3 or 4 (%) | 105 (17.5) | 152 (18.9) | 0.53 |
| Billroth-1 reconstruction (%) | 21 (3.5) | 19 (2.4) | 0.26 |
| Intradiverticular papilla (%) | 35 (5.8) | 25 (3.1) | 0.016 |
| Appearance of the major duodenal papilla (%) | 0.002 | ||
| Type 1 | 265 (44.2) | 358 (44.4) | |
| Type 2 | 276 (46.0) | 342 (42.4) | |
| Type 3 | 26 (4.3) | 74 (9.2) | |
| Type 4 | 33 (5.5) | 32 (4.0) | |
| ERCP performed by non-expert endoscopists | 141 (23.5) | 79 (9.8) | <0.001 |
| Low-volume center (%) | 170 (28.3) | 140 (17.4) | <0.001 |
| Multiple CBD stones (≥2 stones) (%) | 232 (38.7) | 345 (42.8) | 0.13 |
| Large CBD stones (>10 mm) (%) | 106 (17.7) | 148 (18.4) | 0.78 |
| History of cholecystectomy (%) | 59 (9.8) | 97 (12.0) | 0.20 |
| Presence of gallstones (%) | 386 (64.3) | 495 (61.4) | 0.27 |
CBD, common bile duct; ERCP, endoscopic retrograde cholangiopancreatography; SD, standard deviation.
Multivariate Analysis for Factors Predicting Difficult Biliary Cannulation
| Odds ratio | 95% CI | ||
|---|---|---|---|
| ERCP performed by nonexpert endoscopists | 2.5 | 1.9-3.5 | <0.001 |
| Low-volume center | 1.6 | 1.2-2.1 | <0.001 |
| Intradiverticular papilla | 1.3 | 1.1-1.5 | 0.007 |
| Normal serum bilirubin | 1.3 | 1.01-1.7 | 0.038 |
| Absence of acute cholangitis | 1.3 | 1.00-1.7 | 0.049 |
| Appearance of the major duodenal papilla | 0.98 | 0.85-1.1 | 0.77 |
CI, confidence interval; ERCP, Endoscopic retrograde cholangiopancreatography.